Finished product reference
Potassium Iodide
Tablet · Oral · 130 mg
- List code
- 19787
Indications
Indications and Usage Potassium iodide oral solution, USP is for use as an expectorant in the symptomatic treatment of chronic pulmonary diseases where tenacious mucus complicates the problem, including bronchial asthma, bronchitis and pulmonary emphysema.
Dosage and administration (summary)
Dosage and Administration Adults– 0.3 mL (300 mg) or 0.6 mL (600 mg) diluted in one glassful of water, fruit juice or milk 3 to 4 times daily. To minimize gastric irritation, take with food or milk. This medication should be used no longer than necessary to produce the desired effect.
Contraindications
Contraindications Contraindicated in patients with a known sensitivity to iodides.
Warnings and precautions
Warnings Potassium iodide can cause fetal harm, abnormal thyroid function, and goiter when administered to a pregnant woman. Because of the possible development of fetal goiter, if the drug is used during pregnancy or if the patient becomes pregnant during therapy, apprise the patient of the potential hazard.
Pregnancy
Pregnancy: see "Warnings" section.
Storage and supply
Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) . Keep tightly closed and protected from light. For the 30mL bottle, place the child-resistant cap back on the amber glass bottle after using the clear plastic dropper for dispensing.
Source: Potassium Iodide (Potassium Iodide (Saturated)) — US FDA prescribing information, 2026-08-25, DailyMed. Summarised and shortened; the full label governs. Iranian registration, indications and labelling may differ.
Other presentations of the same active ingredient
- Tablet · Oral · 65 mg18932
- Capsule · Oral · 0.016 mCi51092
- Capsule · Oral · 0.03 mCi51093
- Capsule · Oral · 0.05 mCi51094
- Capsule · Oral · 0.1 mCi51091
- Capsule · Oral · 10 mCi52114
- Capsule · Oral · 100 mCi52125
- Capsule · Oral · 15 mCi52115
- Capsule · Oral · 150 mCi52126
- Capsule · Oral · 20 mCi52116
- Capsule · Oral · 200 mCi52127
- Capsule · Oral · 25 mCi52121
- Capsule · Oral · 5 mCi52113
- Capsule · Oral · 50 mCi52124
- Solution · Oral · 100 mCi50895
- Solution · Oral · 150 mCi51086
- Solution · Oral · 200 mCi51087
- Solution · Oral · 50 mCi51088
Reference information for professional sourcing and registration enquiries, not medical advice or a promotion. Drug information is condensed from US FDA prescribing information (public domain, via openFDA and DailyMed) and does not replace the product’s approved labelling in Iran. Availability, origin and documentation are confirmed per enquiry.
Tell us the quantity, the market and the timing.
Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.